Improving prevention of diseases spread by insects in the Midwest
CK22-005, The Midwest Center of Excellence for Vector-Borne Disease
['FUNDING_U01'] · UNIVERSITY OF WISCONSIN-MADISON · NIH-10836969
This study is all about finding better ways to protect people in the Midwest from diseases spread by mosquitoes and ticks, especially as climate change affects these pests, and it aims to improve prevention methods and share helpful information with the community.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WISCONSIN-MADISON (nih funded) |
| Locations | 1 site (MADISON, UNITED STATES) |
| Trial ID | NIH-10836969 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the prevention of human exposure to diseases transmitted by mosquitoes and ticks in the Midwest region. The Midwest Center of Excellence for Vector-Borne Diseases collaborates with various academic and public health institutions to address the impacts of climate change on vector populations and disease outbreaks. The project aims to evaluate existing control methods and develop new strategies to reduce the risk of exposure to these vectors. By gathering and analyzing data, the research will also inform public health outreach and education efforts.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit include individuals living in the Midwest who are at risk of exposure to vector-borne diseases.
Not a fit: Patients who do not reside in the Midwest or are not at risk of exposure to vector-borne diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention strategies against vector-borne diseases, ultimately protecting public health.
How similar studies have performed: Previous research has shown success in developing effective vector control strategies, indicating that this approach has potential for meaningful advancements.
Where this research is happening
MADISON, UNITED STATES
- UNIVERSITY OF WISCONSIN-MADISON — MADISON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: PASKEWITZ, SUSAN M — UNIVERSITY OF WISCONSIN-MADISON
- Study coordinator: PASKEWITZ, SUSAN M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.